Literature DB >> 3371266

Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.

J M Hock1, I Gera, J Fonseca, L G Raisz.   

Abstract

In intact growing rats, intermittent administration of low doses of PTH increases bone mass. As gonadal hormones are considered to be essential for normal bone growth, the anabolic effect of PTH may be mediated or modified by these hormones. The objective of this research was to determine if the anabolic effect of PTH would be altered in female ovariectomized (OVX) and male orchidectomized (ORCHX) rats. Two weeks after ovariectomy, orchidectomy, or sham operations, 5-week-old rats (eight per group) were given daily sc injections of human PTH (1-34) (8 micrograms/100 g) or vehicle. After 12 days of treatment, all rats were killed; castration was confirmed, and sera, femurs, tibias, and kidneys were collected. Calcium (Ca) and dry weight (DW) of trabecular and cortical bone of distal half-femurs were measured. Female OVX rats were osteopenic compared to their sham-operated controls, as the bone mass of distal femurs decreased while body weight increased. In PTH-treated females, total bone Ca and DW per 100 g BW increased significantly by 16% and 21%, respectively, in sham-operated rats and by 21% and 25%, respectively, in OVX rats compared to the appropriate control values. ORCHX rats were also osteopenic, as the bone mass of distal femurs was significantly decreased compared to that in sham-operated males. However, as body weight also decreased, the bone mass per unit BW was not altered. In PTH-treated males, total bone Ca and DW per 100 g BW increased significantly by 34% and 25%, respectively, in sham-operated rats by 32% and 29%, respectively, in ORCHX rats compared to their appropriate control values. Serum Ca, creatinine, and alkaline phosphatase levels were normal and comparable in all rats. We conclude that PTH increased bone mass in control, OVX, and ORCHX rats, and the anabolic response to PTH is not dependent on gonadal hormones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371266     DOI: 10.1210/endo-122-6-2899

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  35 in total

Review 1.  Mechanisms of bone loss and gain in untreated and treated osteoporosis.

Authors:  Juliet Compston
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation.

Authors:  J Chow; J H Tobias; K W Colston; T J Chambers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  Dynamic acoustic radiation force retains bone structural and mechanical integrity in a functional disuse osteopenia model.

Authors:  Sardar M Z Uddin; Yi-Xian Qin
Journal:  Bone       Date:  2015-02-07       Impact factor: 4.398

4.  Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats.

Authors:  Yankel Gabet; David Kohavi; Ralph Müller; Michael Chorev; Itai Bab
Journal:  Osteoporos Int       Date:  2005-04-06       Impact factor: 4.507

Review 5.  Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

Authors:  J Y Reginster; A N Taquet; G Fraikin; C Gosset; B Zegels
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

6.  Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor alpha and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells.

Authors:  H G Schneider; E H Allan; J M Moseley; T J Martin; D M Findlay
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

7.  Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures.

Authors:  E Canalis; M Centrella; W Burch; T L McCarthy
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

8.  Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.

Authors:  V Shen; R Birchman; R Xu; M Otter; D Wu; R Lindsay; D W Dempster
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression.

Authors:  Emi Shimizu; Nagarajan Selvamurugan; Jennifer J Westendorf; Eric N Olson; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

10.  Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone.

Authors:  Shibing Yu; Renny T Franceschi; Min Luo; Jie Fan; Di Jiang; Huiling Cao; Tae-Geon Kwon; Yumei Lai; Jian Zhang; Kenneth Patrene; Kurt Hankenson; G David Roodman; Guozhi Xiao
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.